Polycystic ovary syndrome in women using valproate: A review
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Valproate (VPA) is a highly effective drug successfully employed in several neuropsychiatric diseases. In the last 15 years, an increased prevalence of polycystic ovary syndrome (PCOS) associated with VPA use has been reported in both women with epilepsy and women with bipolar disorders. However, data on this subject are contrasting and it is possible that different factors might play a role in the development of PCOS in these patients. The risk of developing PCOS during VPA treatment seems to be higher in women with epilepsy than in women with bipolar disorders, and this might be due to an underlying neuroendocrine dysfunction related to the seizure disorder. Gynecologists must be aware of the possibility that PCOS in these populations of patients might be related to VPA use, and a careful multi-specialist approach is required for evaluating the risks and benefits of this treatment in the presence of features of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carmina, E., & Lobo, R. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5803 · Cited by 528
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., Adams, J. M., Hwang, C. H., Hall, J. E., & Sachs, G. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.017 · Cited by 134
Joffe, H., Cohen, L. S., Suppes, T., Hwang, C. H., Molay, F., Adams, J. M., Sachs, G. S., & Hall, J. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.027 · Cited by 56 · cited 2×
“Results coming from VPA discontinuation in bipolar patients [56], who showed improvement of menstrual regularity and hyperandrogenism without changes in body weight, also support this hypothesis.”
BackgroundResult
Cited by
Adverse drug reactions induced by valproic acid
Nanau, R. M., & Neuman, M. G. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.06.012 · Cited by 321
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
Hung, J.-H., Hu, L.-Y., Tsai, S.-J., Yang, A. C., Huang, M.-W., Chen, P.-M., Wang, S.-L., Lu, T., & Shen, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097041 · Cited by 152
“The increased prevalence of PCOS associated with valproic acid prescription was observed in both women with epilepsy and women with bipolar disorders [36].”
BackgroundCoyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Kosidou, K., Dalman, C., Widman, L., Arver, S., Lee, B. K., Magnusson, C., & Gardner, R. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.022 · Cited by 78
“Medications such as valproate (ATC code N03AG01) and antipsychotics (ATC code N05A) are reported to induce features of PCOS in women (35,36).”
Background
Metadata
- Authors
- Bilo, L., & Meo, R.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 24
- Issue
- 10
- Pages
- 562-570
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2070507211
- Cited by
- 106
- References
- 3
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.